• EZ Cap Cy5 Firefly Luciferase mRNA: Dual-Mode Assay Revoluti

  2026-08-07

  EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP) bridges high-sensitivity mRNA delivery tracking with robust protein expression in mammalian systems. Its dual-mode fluorescence and bioluminescence readouts empower advanced workflows, troubleshooting, and translational research breakthroughs.

• 5-Azacytidine Triggers ATR-Mediated DNA Damage and Apoptosis

  2026-08-06

  This study demonstrates that 5-Azacytidine, a DNA methyltransferase inhibitor, induces ATR-dependent DNA double-strand break responses and apoptosis in multiple myeloma cells, including drug-resistant variants. Synergistic cytotoxicity is observed when combined with doxorubicin or bortezomib, providing mechanistic insight and rationale for clinical evaluation of these combinations.

• Bcl-xL Maintains Quiescence and Survival in Nutrient-Deprive

  2026-08-06

  Sela et al. reveal that Bcl-xL enforces a slow-cycling, chemoresistant state in nutrient-deprived pancreatic cancer cells, a crucial adaptation for survival in the tumor microenvironment. Their integrated transcriptomic, metabolomic, and CRISPR screening approach identifies Bcl-xL as a key vulnerability, informing strategies to target both proliferative and quiescent cancer cell populations.

• Erastin as a Ferroptosis Inducer: Protocols and Cancer Resea

  2026-08-05

  Erastin’s unique ability to induce ferroptosis enables targeted interrogation of RAS/BRAF-mutant tumor vulnerabilities, with new workflows now validated for overcoming chemoresistance. Cutting-edge research details how Erastin synergizes with chemotherapeutics, offering actionable protocol optimization and troubleshooting for translational cancer biology.

• AZD8055: Technical Workflow Guidance for mTOR Inhibition

  2026-08-05

  AZD8055 is a potent, selective mTOR inhibitor designed for preclinical research that requires reliable, dual inhibition of mTORC1 and mTORC2. It is best suited for mechanistic studies in cancer and metabolic biology, but should not be used for protocols with clinical efficacy endpoints or requiring water solubility.

• Neticonazole Hydrochloride: Imidazole Antifungal in Cancer &

  2026-08-04

  Neticonazole Hydrochloride stands out as a dual-action imidazole antifungal, uniquely empowering both cutaneous candidiasis therapy and advanced colorectal cancer research. Its robust solubility, validated dual mechanisms, and translational relevance make it an indispensable tool for both mycologists and oncologists.

• Patient-Derived Gastric Cancer Assembloids Illuminate Tumor-

  2026-08-04

  This study introduces a patient-derived gastric cancer assembloid model integrating matched tumor organoids with autologous stromal cell subpopulations, enabling more accurate recapitulation of tumor heterogeneity and microenvironmental influences. The findings highlight how stromal components modulate gene expression, drug sensitivity, and resistance mechanisms, offering a robust platform for personalized therapy research.

• L1023 Anti-Cancer Compound Library: Precision Workflows in O

  2026-08-03

  The L1023 Anti-Cancer Compound Library empowers high-throughput oncology research with 1,164 validated small molecules targeting key cancer pathways. Its pre-dissolved, QC-verified format and deep pathway diversity streamline protocol design and enable advanced screening strategies for rapid target deconvolution.

• Sumatriptan’s Anti-Inflammatory Mechanisms: Systematic Revie

  2026-08-03

  Ala et al. systematically reviewed evidence demonstrating sumatriptan's anti-inflammatory actions beyond its established role in migraine management. Their work identifies key molecular targets and discusses implications for drug repurposing in inflammatory conditions.

• Central Pathways in Opioid-Induced Mechanical Hypersensitivi

  2026-08-02

  Yin et al. (2024) identify a specific brain-to-spinal circuit regulating morphine-induced mechanical hypersensitivity and analgesic tolerance in mice. By delineating the neural pathway and its molecular components, this study provides foundational insight for targeted interventions to mitigate opioid side effects in pain research.

• Tigecycline: Advanced Strategies Against Multidrug-Resistant

  2026-08-01

  Explore the scientific foundation and emerging strategies for utilizing Tigecycline, a potent glycylcycline antibiotic, in the fight against multidrug-resistant bacteria. This deep dive connects molecular mechanisms, recent transmission insights, and protocol optimization for translational research.

• Lanabecestat (AZD3293): Reliable BACE1 Inhibition for AD Res

  2026-07-31

  This article addresses common experimental hurdles in Alzheimer's disease research and demonstrates how Lanabecestat (AZD3293), SKU BA8438, delivers reproducible, data-driven solutions for amyloid-beta pathway modulation. Scenario-based guidance covers protocol design, compatibility, data interpretation, and vendor reliability, ensuring rigorous results for cell viability and cytotoxicity assays.

• Degarelix Acetate: Workflow Enhancements for Prostate Cancer

  2026-07-31

  Degarelix acetate, a potent GnRH receptor antagonist, empowers rapid, sustained hormone suppression in prostate cancer research and endocrine modulation assays. This article translates cutting-edge synthesis and protocol data into practical, high-fidelity workflows for both in vitro and in vivo models.

• VER 155008: Adenosine-Derived HSP 70 Inhibitor in Cancer Res

  2026-07-30

  VER 155008 is a potent adenosine-derived HSP 70 inhibitor that disrupts chaperone ATPase activity, induces apoptosis, and impedes proliferation in various cancer models. Its mechanistic specificity and benchmarked efficacy make it a foundational tool for apoptosis assays and studies of Hsp70-mediated pathways.

• 2'-O-Methyladenosine in RNA Modification: Assay Advances & P

  2026-07-30

  2'-O-Methyladenosine nucleoside enables precise profiling of RNA modifications, supporting high-sensitivity quantification and purine metabolism studies. This guide translates the latest UHPLC–MS/MS assay innovations and troubleshooting strategies into practical steps for researchers leveraging APExBIO’s trusted reagent.

455 records 9/31 page Previous Next First page 上5页 678910 下5页 Last page